Drug Information

Drug General Information
Drug ID
D0BP3E
Former ID
DNC005333
Drug Name
(1,1-Difluoro-pentadecyl)-phosphonic acid
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527648]
Formula
C15H31F2O3P
Canonical SMILES
CCCCCCCCCCCCCCC(F)(F)P(=O)(O)O
InChI
1S/C15H31F2O3P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15(16,17)21(18,19)20/h2-14H2,1H3,(H2,18,19,20)
InChIKey
YGXPAGSHLFJKFV-UHFFFAOYSA-N
PubChem Compound ID
11393306
Target and Pathway
Target(s) Lysophosphatidic acid receptor Edg-2 Target Info Inhibitor [527648]
KEGG Pathway Rap1 signaling pathway
Neuroactive ligand-receptor interaction
PI3K-Akt signaling pathway
Gap junction
Pathways in cancer
NetPath Pathway TGF_beta_Receptor Signaling Pathway
Pathway Interaction Database LPA receptor mediated events
Reactome G alpha (q) signalling events
G alpha (i) signalling events
Lysosphingolipid and LPA receptors
WikiPathways Myometrial Relaxation and Contraction Pathways
Gastrin-CREB signalling pathway via PKC and MAPK
Small Ligand GPCRs
GPCR ligand binding
GPCR downstream signaling
References
Ref 527648J Med Chem. 2005 Jul 28;48(15):4919-30.Synthesis, structure-activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activators of PPARgamma, and inhibitors of autotaxin.
Ref 527648J Med Chem. 2005 Jul 28;48(15):4919-30.Synthesis, structure-activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activators of PPARgamma, and inhibitors of autotaxin.